Xcout IntelFoment Bio, Inc.
Foment Bio, Inc. is a biotechnology company developing non-viral, transient gene therapy constructs designed to stimulate in vivo regenerative exosome production. The company's therapies aim to restore tissue microvasculature, resolve inflammation, and rescue cells to treat age-related and cardiometabolic conditions such as heart failure, chronic kidney disease, erectile dysfunction, and impaired wound healing.
Subscribe to see Foment Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Foment Bio, Inc. at a glance
Foment Bio, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $542,550 in May 2024. Xcout tracks 4 named people at Foment Bio, Inc., including Ben Chlebina (CEO).
Foment Bio, Inc. leadership
- Ben ChlebinaCEO
- Ben ChlebinaCEO, CO-FOUNDER
- Dr. Marc PennCMO, CO-FOUNDER
- Mark D'AndreaVP OF CMC & QUALITY
Foment Bio, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $542,550 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Get Foment Bio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Foment Bio, Inc. in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access